Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:1407 (12 June), doi:10.1136/bmj.38118.593900.55 (published 2 June 2004)
Paul E Marik, professor of critical care medicine1, Gary P Zaloga, Medical Director attending intensivist2
1 Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA, 2 Methodist Research Institute,, Indianapolis, IN 46202, USA
Correspondence to: P Marik maripe{at}ccm.upmc.edu
Data sources Medline, Embase, Cochrane controlled trials register, and citation review of relevant primary and review articles.
Study selection Randomised controlled studies that compared enteral nutrition with parenteral nutrition in patients with acute pancreatitis. From 117 articles screened, six were identified as randomised controlled trials and were included for data extraction.
Data extraction Six studies with 263 participants were analysed. Descriptive and outcome data were extracted. Main outcome measures were infections, complications other than infections, operative interventions, length of hospital stay, and mortality. The meta-analysis was performed with the random effects model.
Data synthesis Enteral nutrition was associated with a significantly lower incidence of infections (relative risk 0.45; 95% confidence interval 0.26 to 0.78, P = 0.004), reduced surgical interventions to control pancreatitis (0.48, 0.22 to 1.0, P = 0.05), and a reduced length of hospital stay (mean reduction 2.9 days, 1.6 days to 4.3 days, P < 0.001). There were no significant differences in mortality (relative risk 0.66, 0.32 to 1.37, P = 0.3) or non-infectious complications (0.61, 0.31 to 1.22, P = 0.16) between the two groups of patients.
Conclusions Enteral nutrition should be the preferred route of nutritional support in patients with acute pancreatitis.
Despite the lack of prospective data, gut rest with or without the provision of parenteral nutrition has become regarded as standard care in patients with acute pancreatitis.7 Recent evidence, however, suggests that enteral nutrition may be feasible (and perhaps desirable) in such patients. Animal studies have shown that if the feedings are delivered to the jejunum there are negligible increases in enzyme, bicarbonate, and volume output from the pancreas. This observation has been confirmed in humans.8 Some experts suggest that enteral feeding stimulates lysosomal movement to the cell surface, minimising intracellular release of pancreatic enzymes, and may be therapeutic in patients with acute pancreatitis. In addition, enteral nutrition reduces production of proinflammatory mediators.
The most severe complication of acute pancreatitis is pancreatic infection. Many studies report that total parenteral nutrition impairs humoral and cell mediated immunity, increases the vigour of the proinflammatory response, increases bacterial translocation, and increases infection rates in various critically ill patients.1 Compared with total parenteral nutrition, enteral nutrition is associated with improved immune function and reduced infections. While several randomised controlled studies have been performed comparing total parenteral nutrition with enteral nutrition in patients with pancreatitis these studies have been underpowered and hence the differences were not always statistically significant. Furthermore, the magnitude of the treatment effect remains unknown. We therefore performed a meta-analysis of available studies that compared total parenteral nutrition with enteral nutrition to provide an estimate of the treatment effect on important clinical outcomes.
Study selection and data extraction
Trials had to be randomised clinical trials in patients admitted to hospital with acute pancreatitis. The intervention was enteral nutrition versus parenteral nutrition, and trials had to have as a primary outcome variable at least one of the following: number of infections, total number of non-infectious complications, number of surgical interventions, length of hospital stay, and hospital mortality.
Data extraction
We independently abstracted data from all studies using standardised forms. Data were abstracted on study design, setting, and population; severity of illness; the exact methods of nutritional support; and the outcome variables listed above. In calculating each outcome variable, we used intention to treat data. Disagreements were resolved by discussion and, if necessary, contact with the authors, who also supplied missing data.
We used the APACHE II (acute physiology and chronic health evaluation) score (< 10 indicates mild disease), Ranson score, or Glasgow score (
3 indicates severe pancreatitis) to quantify the severity of pancreatitis. The methodological quality of the studies was scored with the Jadad composite scale,9 (low quality studies score
2 and high quality studies score of
3).
Data analysis
Infections, complications other than infections, operative interventions, and mortality were binary variables, and length of hospital stay was a continuous variable. The data analysis was performed using the random effects model. The relative risk and continuous data outcomes are presented with 95% confidence intervals. We tested heterogeneity between trials with
2 tests.
While all included studies randomised patients to enteral or parenteral nutritional support, selection of patients and study design differed somewhat between the studies. The inclusion criteria for all studies included patients admitted to hospital with acute pancreatitis characterised by abdominal pain with raised serum amylase and lipase activity. In all studies patients were enrolled within 48 hours after admission to hospital. Enteral nutrition was delivered through a nasojejunal tube that had been placed endoscopically or radiographically. Indications for operative intervention in all studies included persistent or deteriorating organ failure despite maximal intensive care, verified infected pancreatic necrosis, and large symptomatic or infected pseudocyst formation. See bmj.com for differences between studies.
Primary outcomes
Figure 1 shows the relative risks and 95% confidence intervals for infections, complications other than infections, surgical intervention, and mortality.
|
InfectionsInfections recorded included pneumonia, abdominal abscess, pancreatic abscess, wound infections, and blood stream infection. Overall, there was a significantly lower risk of infection in the patients who received enteral nutrition compared with those who received parental nutrition (fig 2).
|
Complications other than infectionsFive studies reported on complications other than infectious, including adult respiratory distress syndrome, multi-organ failure, acute pseudocysts, and pancreatic fistula. There was no significant difference in the incidence between the enteral and total parenteral nutrition group (0.61, 0.31 to 1.22, P = 0.16).
Surgical interventionsFour studies reported on the need for surgical intervention for the management of pancreatitis. The requirement for surgery was significantly lower in the patients fed enterally (0.48, 0.23 to 0.99, P = 0.05). Length of hospital stayAll studies included in the meta-analysis provided information on length of hospital stay, which was significantly shorter in the enteral nutrition group (mean reduction of 2.9 days, 1.6 days to 4.3 days; P < 0.001). There was, however, significant heterogeneity between studies (
2 = 16.5, P = 0.0056).
MortalityAll studies reported on hospital mortality. There was no significant difference in hospital mortality between the enteral and total parenteral nutrition groups (relative risk 0.66, 0.32 to 1.37, P = 0.3).
The finding that parenteral nutrition increases infections in patients with pancreatitis is not unexpected and is supported by a large body of experimental and clinical data. Experimental studies show that total parenteral nutrition results in rapid and severe atrophy of lymphoid tissue associated with the gut and increases bacterial translocation. Lymphoid tissue associated with the gut is the source of most mucosal immunity in humans. In addition, total parenteral nutrition is associated with impaired B and T cell lymphocyte function, altered leucocyte chemotaxis, impaired phagocytosis, and impaired bacterial and fungal killing. Experimental models of sepsis have shown a significantly higher mortality in animals receiving parenteral compared with enteral nutrition. These experimental data are supported by clinical studies, which have consistently shown a higher risk of infection in patients receiving total parenteral nutrition.16-21 Non-randomised clinical studies of use of total parenteral nutrition in patients with acute pancreatitis also suggest increased infection rates.22-24
Parenteral nutrition is also associated with a more pronounced proinflammatory response. Clinical and experimental studies have shown higher levels of both local and systemic proinflammatory mediators with parenteral compared with enteral nutrition,25 including higher concentrations of interleukin 6, interleukin 8 and C reactive protein.
The most severe complication of acute pancreatitis is pancreatic infection. The risk is related to the extent of pancreatic necrosis and therefore the severity of the disease. The finding that the microorganisms causing pancreatic infection are common enteric pathogens implies that bacterial translocation from the intestinal tract to pancreas may have a role. Lack of enteral feeding results in atrophy of the gastrointestinal mucosa, bacterial overgrowth, increased intestinal permeability, and translocation of bacteria or bacterial products into the circulation. In addition, changes in enteral nutrient supply, osmolality, or pH with total parenteral nutrition may induce bacteria to express virulence genes that enhance bacterial adhesion and translocation or the production of local toxins that may act locally or systemically. Enteral nutrition, on the other hand, may switch off these virulence genes.
The studies reported in this analysis provided enteral nutrition through feeding tubes in the small bowel. Most were stated to be in the jejunal location. Most cases of acute pancreatitis are mild and self limiting, with serum enzyme activities returning toward normal within two to four days. We suggest placement of a jejunal feeding tube and the initiation of early enteral feeding in patients with moderate and severe pancreatitis (> 3 Ranson criteria). In patients with mild pancreatitis placement of a jejunal feeding tube and the initiation of enteral feeding should be considered in those patients who are unable to resume oral feeding after 48 hours of conservative therapy. Previously well nourished patients with mild pancreatitis who can resume oral intake within a few days may not benefit from enteral tube feeding. On the other hand, it is likely that previously malnourished patients and patients unable to resume oral intake within a few days would benefit from nutritional support.
This systematic review has several limitations. The studies included are of relatively poor quality, with four of the six studies having a Jadad score of < 3.9 None of the studies were blinded and there was only small number of patients included in the analysis (n = 263). The overall small sample size led to wide confidence intervals. Furthermore, the included studies had differing inclusion and exclusion criteria (and therefore differing severity of illness). The difference in severity of disease may explain the heterogeneity in the length of stay between studies. The limitations of the individual included studies restrict the strength of the conclusion that can be drawn from this review. However, our results are supported by an extensive body of experimental and clinical data, which has shown the adverse effects of parenteral compared with enteral nutrition.
|
This is the abridged version of an article that was posted on bmj.com on 2 June 2004: http://bmj.com/cgi/doi/10.1136/bmj.38118.593900.55 Competing interests: None declared.
Ethical approval: Not required.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses